These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11491102)

  • 1. BCG report rosy on genomics.
    Fletcher L
    Nat Biotechnol; 2001 Aug; 19(8):703. PubMed ID: 11491102
    [No Abstract]   [Full Text] [Related]  

  • 2. The end of the beginning for genomic medicine.
    Bailey D; Zanders E; Dean P
    Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of bacteriophage genomics.
    McGrath S; Fitzgerald GF; van Sinderen D
    Curr Opin Biotechnol; 2004 Apr; 15(2):94-9. PubMed ID: 15081045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray technology: an array of opportunities.
    Gershon D
    Nature; 2002 Apr; 416(6883):885-91. PubMed ID: 11976691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Will genes become an engine to the industry?].
    Nylund S; Sibakov M
    Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequenom steps toward drug development.
    Dorey E
    Nat Biotechnol; 2001 Jul; 19(7):600-1. PubMed ID: 11433255
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomics joint venture 2.
    Davies MJ
    Trends Biotechnol; 2001 May; 19(5):163. PubMed ID: 11301124
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 9. Connecting genes, drugs and diseases.
    Weinstein JN; Pommier Y
    Nat Biotechnol; 2006 Nov; 24(11):1365-6. PubMed ID: 17093484
    [No Abstract]   [Full Text] [Related]  

  • 10. Arnold Demain.
    Demain A
    Nat Biotechnol; 2011 Mar; 29(3):193. PubMed ID: 21390012
    [No Abstract]   [Full Text] [Related]  

  • 11. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug discovery--an operating model for a new era.
    Myers S; Baker A
    Nat Biotechnol; 2001 Aug; 19(8):727-30. PubMed ID: 11479559
    [No Abstract]   [Full Text] [Related]  

  • 13. Profiles of four top biotech companies in India.
    Suresh N; Rao ChS
    Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
    [No Abstract]   [Full Text] [Related]  

  • 14. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech boom.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):480-3. PubMed ID: 16049469
    [No Abstract]   [Full Text] [Related]  

  • 16. 2011 in reflection.
    Mullard A
    Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
    [No Abstract]   [Full Text] [Related]  

  • 17. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 18. Free genome databases finally defeat Celera.
    Marris E
    Nature; 2005 May; 435(7038):6. PubMed ID: 15874985
    [No Abstract]   [Full Text] [Related]  

  • 19. New pharma-biotech company formation in India.
    Saberwal G
    Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT40-2. PubMed ID: 11221715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.